Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Vitamin D and multiple sclerosis: Potential pathophysiological role and clinical implications.

Dudani SJ, Kalhan S, Sharma SP.

Int J Appl Basic Med Res. 2011 Jul;1(2):71-4. doi: 10.4103/2229-516X.91146.

2.

Vitamin D immunomodulatory potential in multiple sclerosis.

Slavov GS, Trenova AG, Manova MG, Kostadinova II, Vasileva TV, Zahariev ZI.

Folia Med (Plovdiv). 2013 Apr-Jun;55(2):5-9. Review.

PMID:
24191393
3.

Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?

Pierrot-Deseilligny C, Souberbielle JC.

Brain. 2010 Jul;133(Pt 7):1869-88. doi: 10.1093/brain/awq147. Review.

PMID:
20584945
4.

Clinical implications of a possible role of vitamin D in multiple sclerosis.

Pierrot-Deseilligny C.

J Neurol. 2009 Sep;256(9):1468-79. doi: 10.1007/s00415-009-5139-x. Epub 2009 Apr 28. Review.

5.

Clinical utility of vitamin d testing: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(2):1-93. Epub 2010 Feb 1.

6.

[The role of vitamin D in the pathogenesis and course of multiple sclerosis].

Góral A, Brola W, Kasprzyk M, Przybylski W.

Wiad Lek. 2015;68(1):60-6. Review. Polish.

PMID:
26094335
7.

Environmental factors in multiple sclerosis.

Ascherio A.

Expert Rev Neurother. 2013 Dec;13(12 Suppl):3-9. doi: 10.1586/14737175.2013.865866. Review.

PMID:
24289836
8.

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis.

Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R, Gagne D, D'Souza C, Ursell M, O'Connor P.

Neurology. 2010 Jun 8;74(23):1852-9. doi: 10.1212/WNL.0b013e3181e1cec2. Epub 2010 Apr 28. Erratum in: Neurology. 2010 Aug 3;75(5):480. Neurology. 2010 Sep 14;75(11):1029. Dosage error in article text.

9.

Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Pierrot-Deseilligny C, Souberbielle JC.

Ther Adv Neurol Disord. 2013 Mar;6(2):81-116. doi: 10.1177/1756285612473513.

10.

25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis.

Soilu-Hänninen M, Airas L, Mononen I, Heikkilä A, Viljanen M, Hänninen A.

Mult Scler. 2005 Jun;11(3):266-71.

PMID:
15957505
11.

Can we prevent or treat multiple sclerosis by individualised vitamin D supply?

Dörr J, Döring A, Paul F.

EPMA J. 2013 Jan 29;4(1):4. doi: 10.1186/1878-5085-4-4.

12.

Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season.

Alemzadeh R, Kichler J, Babar G, Calhoun M.

Metabolism. 2008 Feb;57(2):183-91. doi: 10.1016/j.metabol.2007.08.023.

PMID:
18191047
13.

High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis.

Nieves J, Cosman F, Herbert J, Shen V, Lindsay R.

Neurology. 1994 Sep;44(9):1687-92.

PMID:
7936297
14.

Vitamin D treatment in multiple sclerosis.

Myhr KM.

J Neurol Sci. 2009 Nov 15;286(1-2):104-8. doi: 10.1016/j.jns.2009.05.002. Epub 2009 Jun 23. Review.

PMID:
19549608
16.

Vitamin D: a natural inhibitor of multiple sclerosis.

Hayes CE.

Proc Nutr Soc. 2000 Nov;59(4):531-5. Review.

PMID:
11115787
17.

Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.

Faridar A, Eskandari G, Sahraian MA, Minagar A, Azimi A.

Acta Neurol Belg. 2012 Dec;112(4):327-33. doi: 10.1007/s13760-012-0108-z. Epub 2012 Jul 6. Review.

PMID:
22767049
18.

Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection.

Correale J, Gaitán MI.

Acta Neurol Scand. 2015;132(199):46-55. doi: 10.1111/ane.12431. Review.

PMID:
26046559
20.

Vitamin D for the management of multiple sclerosis.

Jagannath VA, Fedorowicz Z, Asokan GV, Robak EW, Whamond L.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD008422. doi: 10.1002/14651858.CD008422.pub2. Review.

PMID:
21154396

Supplemental Content

Support Center